To the Editor The US Preventive Services Task Force (USPSTF)1 recommended high-intensity counseling for adults with obesity, followed by regular contact for maintenance of weight loss. The task force did not issue recommendations for pharmacotherapy because of (1) perceived lack of generalizability of the clinical trial findings, owing to stringent inclusion criteria and run-in periods; (2) high rates of dropout in the trials; and (3) lack of data “about the maintenance of improvement after discontinuation of pharmacotherapy.”
Tsai AG, Apovian C, Kaplan L. Weight Loss Interventions in Adults. JAMA. 2019;321(9):900. doi:10.1001/jama.2018.20287
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: